Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bromide, Vecuronium
2. Citrate, Vecuronium
3. Hydrobromide, Vecuronium
4. Hydrochloride, Vecuronium
5. Maleate, Vecuronium
6. Nc 45
7. Nc-45
8. Nc45
9. Norcuron
10. Org Nc 45
11. Org Nc45
12. Org-nc 45
13. Org-nc-45
14. Org-nc45
15. Orgnc 45
16. Orgnc45
17. Phosphate, Vecuronium
18. Vecuronium
19. Vecuronium Bromide, Quaternary Ion
20. Vecuronium Citrate
21. Vecuronium Hydrobromide
22. Vecuronium Hydrochloride
23. Vecuronium Maleate
24. Vecuronium Phosphate
1. 50700-72-6
2. Norcuron
3. Org Nc 45
4. Vecuronii Bromidum
5. Bromuro De Vecuronio
6. Vecuronium (bromide)
7. Bromure De Vecuronium
8. Org-nc 45
9. 7e4php5n1d
10. Acetate;bromide
11. Chebi:9940
12. Musculax
13. Nsc-759184
14. 1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium Bromide, Diacetate
15. Dsstox_cid_3736
16. (+)-1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium Bromide
17. Dsstox_rid_77174
18. Dsstox_gsid_23736
19. [(2s,3s,10s,13s,16s,17r)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate;bromide
20. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate;bromide
21. Nc-45
22. 1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide Hydrate
23. Cas-50700-72-6
24. Vecuronii Bromidum [inn-latin]
25. Ncgc00167467-01
26. Bromure De Vecuronium [inn-french]
27. Bromuro De Vecuronio [inn-spanish]
28. Einecs 256-723-9
29. Unii-7e4php5n1d
30. Vecronium Bromide
31. Norcuron (tn)
32. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]
33. Mfcd00867762
34. Vecuronium Bromide [usan:usp:inn:ban:jan]
35. 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate
36. Schembl22250
37. Mls001424317
38. Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, Bromide
39. Vecuronium Bromide [mi]
40. Chembl1200629
41. Dtxsid1023736
42. Vecuronium Bromide [inn]
43. Vecuronium Bromide [jan]
44. Hy-b0118a
45. Vecuronium For System Suitability
46. Vecuronium Bromide [usan]
47. Hms2052i21
48. Hms3715l15
49. Hms3884c15
50. Vecuronium Bromide [vandf]
51. Vecuronium Bromide [mart.]
52. 1-[(1s,2s,4s,5s,7s,10r,11s,13s,14r,15s)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(piperidin-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium Bromide
53. Bcp06528
54. Vecuronium Bromide (jan/usp/inn)
55. Vecuronium Bromide [usp-rs]
56. Vecuronium Bromide [who-dd]
57. Tox21_112471
58. Akos005145904
59. Akos007930694
60. Tox21_112471_1
61. Ac-2000
62. Ccg-101147
63. Cs-1881
64. Nc00397
65. Nsc 759184
66. Vecuronium Bromide [ep Impurity]
67. Vecuronium Bromide [orange Book]
68. Ncgc00167467-03
69. Vecuronium Bromide [ep Monograph]
70. 1-((2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium Bromide
71. Ds-12625
72. Piperidinium, 1-(3-alpha,17-beta-diacetoxy-2-beta-piperidino-5-alpha-androstan-16-beta-yl)-1-methyl-, Bromide
73. Smr000471625
74. Vecuronium Bromide [usp Monograph]
75. S1405
76. V0120
77. D00767
78. Pancuronium Bromide Impurity, Vecuronium Bromide -
79. Sr-01000763634
80. Pancuronium Bromide Impurity D [ep Impurity]
81. Q-101014
82. Sr-01000763634-3
83. Q27108523
84. Z1551429734
85. Vecuronium Bromide, European Pharmacopoeia (ep) Reference Standard
86. Pancuronium Bromide Impurity, Vecuronium Bromide - [usp Impurity]
87. Vecuronium Bromide, United States Pharmacopeia (usp) Reference Standard
88. 1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium Bromide
89. Vecuronium Bromide, Pharmaceutical Secondary Standard; Certified Reference Material
90. Vecuronium For Peak Identification, European Pharmacopoeia (ep) Reference Standard
91. Vecuronium For System Suitability, European Pharmacopoeia (ep) Reference Standard
92. (2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane Bromide
93. (2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane Bromide
94. 1-((2s,3s,5s,10s,13s,16s,17r)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium Bromide
95. 1-((2s,3s,5s,10s,13s,16s,17r)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-iumbromide
96. 1-(3.alpha.,17.beta.-dihydroxy-2.beta.-piperidino-5.alpha.-androstan-16.beta.,5.alpha.-yl)-1-methylpiperidinium Bromide, Diacetate
97. 1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide
98. 1-[3alpha,17beta-bis(acetoxy)-2beta-(1-piperidinyl)-5alpha-androstan-16beta-yl]-1-methylpiperidinium Bromide
99. Piperidinium, 1-((2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, Bromide
Molecular Weight | 637.7 g/mol |
---|---|
Molecular Formula | C34H57BrN2O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 636.35017 g/mol |
Monoisotopic Mass | 636.35017 g/mol |
Topological Polar Surface Area | 55.8 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 958 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Vecuronium bromide |
Drug Label | Vecuronium Bromide for Injection is a nondepolarizing neuromuscular blocking agent of intermediate duration, chemically designated as 1-(3,17-Dihydroxy-2-piperidino-5- androstan-16,5-yl)-1-methylpiperidinium bromide, diacetate. The struct... |
Active Ingredient | Vecuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/vial; 20mg/vial |
Market Status | Prescription |
Company | Bedford; Hospira; Teva Pharms Usa; Sun Pharma Global; Mustafa Nevzat; Agila Speclts |
2 of 2 | |
---|---|
Drug Name | Vecuronium bromide |
Drug Label | Vecuronium Bromide for Injection is a nondepolarizing neuromuscular blocking agent of intermediate duration, chemically designated as 1-(3,17-Dihydroxy-2-piperidino-5- androstan-16,5-yl)-1-methylpiperidinium bromide, diacetate. The struct... |
Active Ingredient | Vecuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/vial; 20mg/vial |
Market Status | Prescription |
Company | Bedford; Hospira; Teva Pharms Usa; Sun Pharma Global; Mustafa Nevzat; Agila Speclts |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
Nicotinic Antagonists
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Vecuronium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vecuronium Bromide, including repackagers and relabelers. The FDA regulates Vecuronium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vecuronium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vecuronium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vecuronium Bromide supplier is an individual or a company that provides Vecuronium Bromide active pharmaceutical ingredient (API) or Vecuronium Bromide finished formulations upon request. The Vecuronium Bromide suppliers may include Vecuronium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Vecuronium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vecuronium Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Vecuronium Bromide active pharmaceutical ingredient (API) in detail. Different forms of Vecuronium Bromide DMFs exist exist since differing nations have different regulations, such as Vecuronium Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vecuronium Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Vecuronium Bromide USDMF includes data on Vecuronium Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vecuronium Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vecuronium Bromide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vecuronium Bromide Drug Master File in Japan (Vecuronium Bromide JDMF) empowers Vecuronium Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vecuronium Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Vecuronium Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vecuronium Bromide suppliers with JDMF on PharmaCompass.
A Vecuronium Bromide written confirmation (Vecuronium Bromide WC) is an official document issued by a regulatory agency to a Vecuronium Bromide manufacturer, verifying that the manufacturing facility of a Vecuronium Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vecuronium Bromide APIs or Vecuronium Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Vecuronium Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Vecuronium Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vecuronium Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vecuronium Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vecuronium Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vecuronium Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vecuronium Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vecuronium Bromide suppliers with NDC on PharmaCompass.
Vecuronium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vecuronium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vecuronium Bromide GMP manufacturer or Vecuronium Bromide GMP API supplier for your needs.
A Vecuronium Bromide CoA (Certificate of Analysis) is a formal document that attests to Vecuronium Bromide's compliance with Vecuronium Bromide specifications and serves as a tool for batch-level quality control.
Vecuronium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Vecuronium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vecuronium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Vecuronium Bromide EP), Vecuronium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vecuronium Bromide USP).
LOOKING FOR A SUPPLIER?